»
Antikörper
»
anti-Cytomegalovirus, Lower Matrix Protein, Pp65 Antikörper
Cytomegalovirus, Lower Matrix Protein, Pp65 Antikörper
| Antigen |
|
| Klonalität |
Monoklonal (3A12) |
|
Wirt
|
|
|
Applikation
|
Alternativen Western Blot (WB), Immunfluoreszenz (IF), ELISA
|
| Produktnummer |
ABIN265537 |
| Menge |
100 ug (1.0 mg/ml) (Varianten) |
| Preis |
225,27 € Zzgl. Versandkosten €20,00, €20,00 Trockeneispauschale sowie MWSt
|
| Lieferung nach |
|
| Verfügbarkeit |
Lieferung in 5 Werktagen |
|
Weitere Bezeichnung
|
Cytomegalovirus pp65 (CMV pp65) Lower Matrix Protein
|
|
Format
|
Affinity-purified
|
|
Isotyp
|
IgG2a kappa (Passende Sekundärantikörper)
|
|
Klon
|
3A12
|
|
Beschreibung
|
Synonyms: Cytomegalovirus pp65 Lower Matrix Protein, UL83, LMP, vp65, ICP27
|
|
Applikationshinweise
|
Western Blotting: > 1:16.000. Immunofluorescence: 1+ at 1:3.200. ELISA: 0.100 at 1:102.400
|
|
Konzentration
|
1.0 mg/ml
|
|
Reinheit
|
Affinity Purified, > 95% IgG by SDS-PAGE
|
|
Buffer
|
Phosphate Buffered Saline pH 7.4 (no azide)
|
|
Forschungsgebiet
|
Virologie
|
|
Beschränkungen
|
Nur für Forschungszwecke einsetzbar
|
|
Publikationen
|
Gao, Kagele, Smallenberg et al.: "Nucleocytoplasmic Shuttling of Human Cytomegalovirus UL84 is Essential for Virus Growth." in: Journal of virology, 2010 (PubMed).
E, Pickering, Debatis et al.: "An E2F1-mediated DNA damage response contributes to the replication of human cytomegalovirus." in: PLoS pathogens, Vol. 7, Issue 5, pp. e1001342, 2011 (PubMed).
Kagele, Rossetto, Tarrant et al.: "Analysis of the interactions of viral and cellular factors with human cytomegalovirus lytic origin of replication, oriLyt." in: Virology, Vol. 424, Issue 2, pp. 106-14, 2012 (PubMed).
|
Alternativen zu Antigen "Cytomegalovirus, Lower Matrix Protein, Pp65", Typ "Antikörper" finden